CAPR - What's Going On With Capricor Therapeutics Stock Friday? | Benzinga
Capricor Therapeutics, Inc. (NASDAQ:CAPR) shares are trading higher on Friday. The company announced the long-term benefits of deramiocel for the treatment of duchenne muscular dystrophy (DMD).
What Happened: The biotechnology company said deramiocel increased cardiac function based on several different measures.
The study found improvements in left ventricular ejection fraction, ...